ThomasNet Home   |   Promote Your Business
Home  |   My ThomasNet News®  |   Industry Market Trends  |   Submit Release  |   Advertise  |   About Us May 25, 2012  

Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

Developer One Software
10437 W Innovation Dr., Suite 212
Milwaukee,, WI, 53226
USA



Press release date: February 22, 2008

MOUNTAIN VIEW, Calif., Feb. 22 - Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at Jesup and Lamont's 2008 Emerging Growth Stock Conference on February 28, 2008 at the Walt Disney Contemporary resort in Orlando, FL. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will present the company's business strategy and financial results on February 28, 2008, at 8:15 a.m. Eastern Standard Time (5:15 a.m. PST).

Attendance at the conference is by invitation only. A live webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at Jesup and Lamont's website at http://jesuplamontconferences.com/. You must first register to have access to the webcast.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California.

Information about Pharsight is available at http://www.pharsight.com/

Source: Pharsight Corporation

CONTACT: Investors, Douglas Sherk, +1-415-896-6820,

or Matthew Selinger, +1-415-896-6817,

or Media, Steve DiMattia, +1-646-201-5445, all of EVC +Group

Web site: http://www.pharsight.com/ http://jesuplamontconferences.com/
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Software displays model-based drug compound profile.
Software orchestrates pharmacokinetic analyses.
Software automatically validates WinNonlin installations.
Software enables in vivo-in vitro correlations.
Drug Modeling Software uses Microsoft® .NET framework.
More ....
 Other News from this company:
FDA and Pharsight Continue to Collaborate under CRADA
Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
Pharsight Invited to Present at the Noble Financial Two Double-O-Seven Conference
Pharsight Launches New Client Service Offering, Expands Management Team
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2012 Thomas Publishing Company
Terms of Use - Privacy Policy



Error close

Please enter a valid email address